>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance:

  • LOVE -5.5%, LULU -4.7%, NX -4.4%, OXM -4.3%, CIEN -3.4%, NDSN -2.4%, ALB -1.5% (introduces 2024 financial outlook and 5-year CAGR) TLRD -1%

Other news:

  • AKTS -10.5% (prices 4.8 mln common stock offering at $6.25/share)
  • MNRL -2.1% (prices 11 mln share Class A common stock offering at $18.10 per share)
  • ASMB -2% (prices offering of 5,151,515 shares of its common stock at $16.50 per share)
  • GME -2% (continued weakness)
  • NFLX -1.3% (being attributed to disappointing Irishman viewership numbers)

Analyst comments:

  • MMSI -4% (downgraded to Underweight from Equal Weight at Wells Fargo)
  • ANSS -2.6% (downgraded to Underweight from Neutral at JP Morgan)
  • GKOS -2.6% (downgraded to Underweight from Overweight at Wells Fargo)
  • ADSK -1.7% (downgraded to Underweight from Neutral at JP Morgan)
  • WST -1.5% (downgraded to Underperform from Neutral at BofA/Merrill)

>>> USGapping up

Gapping up
In reaction to strong earnings/guidance:

  • FORM +5.3%, LL +2.8%, DAL +1.9% (guidance) MESA +1.5%

Other news:

  • AMRX +22.7% (receives abbreviated new drug application approval for EluRyng, the first generic NuvaRing)
  • LMPX +15.5% (Pres/CEO disclosed the purchase of ~132K shares worth ~$1.7 mln)
  • FTSV +4.8% (prices underwritten public offering of 4.86 mln shares of its common stock at a price to the public of $35.00 per share)
  • PBYI +2.4% (presents results from ongoing Phase II clinical trial of neratinib)
  • YRCW +2% (YRC Worldwide announces departure of CFO Stephanie Fisher; appoints Jamie Pierson as CFO and Matt Doheny as Chairman; provides quarter-to-date operating data)
  • LVGO +1.9% (prices underwritten public offering of 2,777,327 shares of its common stock by certain selling stockholders at a price of $27.00 per share)
  • WPP +1.7% (announces up to GBP 300 mln share repurchase agreement)
  • PRVB +1.7% (continues to expect that it will commence a rolling BLA submission for PRV-031 in the middle of 2020)
  • CVA +1.4% (signs concession agreement for construction and operation of new Energy-from-Waste facility in China)
  • FCAU +1.3% (Fiat Chrysler confirms ratification of four-year collective bargaining agreement)

Analyst comments:

  • AMRS +8.6% (initiated with a Outperform at Oppenheimer; tgt $8)
  • SWAV +3.9% (upgraded to Overweight from Equal Weight at Wells Fargo)
  • MODN +2.3% (upgraded to Overweight from Neutral at JP Morgan)
  • GE +2.1% (coverage assumed/upgraded to Buy from Neutral at UBS)
  • BHC +2% (upgraded to Overweight from Neutral at JP Morgan)
  • HUYA +1.9% (initiated with a Buy at Needham)
  • SBUX +1.7% (upgraded to Overweight from Neutral at JP Morgan)
  • OII +1.5% (upgraded to Outperform from In-line at Evercore ISI)
  • SNPS +1.5% (upgraded to Overweight from Neutral at JP Morgan)
  • GMED +1% (upgraded to Overweight from Equal Weight at Wells Fargo)
  • KR +0.8% (upgraded to Outperform from In-line at Evercore ISI)
  • HSBC +0.6% (upgraded to Buy from Neutral at BofA/Merrill)

>>> US Early premarket gappers

Early premarket gappers

  • Gapping up:
    • LMPX +20.9%, FORM +10.7%, AMRS +10.2%, TLRD +3.1%, PBYI +2.1%, CVA +2%, YRCW +2%, GE +1.7%, WPP +1.7%, FCAU +1.3%, LVGO +1.3%, LL +1.3%, FTSV +0.7%, AZN +0.6%
  • Gapping down:
    • AKTS -9.2%, ASMB -6.3%, NX -4.4%, OXM -4.3%, LULU -4.2%, NDSN -2.4%, MNRL -1.8%, RH -1.4%, NFLX -0.9%, ZTS -0.7%, GME -0.5%